USPTO Patents Application 09648420

Doc code: RCEX pto/sb/30efs (07-09)

Doc description: Request for Continued Examination (RCE) Approved for use through 07/31/2012. omb 065i-003i

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.

REQUEST FOR CONTINUED EXAMINATION (RCE)TRANSMITTAL
(Submitted Only via EFS-Web)

Application
Nunnber

09648420

Filing
Date

2000-08-23

Docket Number
(if applicable)

60095-39

Art
Unit

2457

First Manned
Inventor

Day, Richard D.

Examiner
Name

Todd, Gregory G.

This is a Request for Continued Examination (RCE) under 37 CFR 1.114 of the above-identified application.

Request for Continued Examination (RCE) practice under 37 CFR 1.114 does not apply to any utility or plant application filed prior to June 8,
1995, or to any design application. The Instruction Sheet for this form is located at WWW.USPTO.GOV

SUBMISSION REQUIRED UNDER 37 CFR 1 .1 14

Note: If the RCE is proper, any previously filed unentered amendments and amendments enclosed with the RCE will be entered in the order
in which they were filed unless applicant instructs otherwise. If applicant does not wish to have any previously filed unentered amendment(s)
entered, applicant must request non-entry of such amendment{s).

□

Previously submitted. If a final Office action is outstanding, any amendments filed after the final Office action may be considered as a
submission even if this box is not checked.

I I Consider the arguments in the Appeal Brief or Reply Brief previously filed on

□ Other

Enclosed
[x] Amendment/Reply

[X] Information Disclosure Statement (IDS)

I I Affidavit(s)/ Declaration(s)

□ Other

MISCELLANEOUS

□

Suspension of action on the above-identified application is requested under 37 CFR 1 .1 03(c) for a period of months
(Period of suspension shall not exceed 3 months; Fee under 37 CFR 1 .17(1) required)

□ Other

FEES

The RCE fee under 37 CFR 1.17(e) is required by 37 CFR 1.114 when the RCE is filed.

The Director is hereby authorized to charge any underpayment of fees, or credit any overpayments, to
Deposit Account No 501269

SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED

[X] Patent Practitioner Signature
I I Applicant Signature

EFS - Web 2.1.15

Doc code: RCEX pto/sb/30efs (07-09)

Doc description: Request for Continued Examination (RCE) Approved for use through 07/31/2012. omb 065i-003i

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.

Signature of Registered U.S. Patent Practitioner

Signature

/Joshua T. Matt/

Date (YYYY-MM-DD)

2010-09-29

Name

Josinua T. Matt

Registration Number

55435

This collection of information is required by 37 CFR 1.114. The information Is required to obtain or retain a benefit by the public which is to
file {and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.1 1 and 1.14. This collection is
estimated to take 12 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time
will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for
reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce,
P.O. Box 1450, Alexandria, VA 22313-1450.

If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.

EPS - Web 2.1.15

Privacy Act Statement

The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection wWh your submission of the
attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be
advised that: (1 ) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information
solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office
is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested
information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
result in termination of proceedings or abandonment of the application or expiration of the patent.

The information provided by you in this form will be subject to the following routine uses:

1 . The information on this form will be treated confidentially to the extent allowed under the Freedom of Information
Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
Department of Justice to determine whether the Freedom of Information Act requires disclosure of these records.

2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
negotiations.

3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
request involving an individual, to whom the record pertains, when the individual has requested assistance from the
Member with respect to the subject matter of the record.

4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need
for the information in order to perform a contract. Recipients of information shall be required to comply with the
requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).

5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization,
pursuant to the Patent Cooperation Treaty.

6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).

7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services,
or his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
determinations about individuals.

8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of
the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may
be disclosed, subject to the limitations of 37 CFR 1 .14, as a routine use, to the public if the record was filed in an
application which became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspections or an issued patent.

9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.

EPS - Web 2.1.15